News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie
Collage photo of Ajay Major and Jennifer Crombie
Nov 14, 2024, 12:33

Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie

Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X about a new abstract by Jennifer Crombie, Hematologist/oncologist at Dana Farber’s Cancer Center:

“Liso-cel in DLBCL with secondary CNS diagnosis.

  • 36 patients (CIBMTR), 83% parenchymal, 97% active diagnosis at CAR
  • ORR 64%, CR 53%, 1-yr DOR 55%
  • 1-yr PFS 36%, OS 39%, almost all deaths from POD
  • G3 CRS 8%, ICANS 22% (no G4-5)

Still bad outcomes in this setting.”

“Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry”

Authors: Sairah Ahmed, Avyakta Kallam, Matthew Frigault, Marcelo Pasquini, Jennifer Crombie et al.

Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie

More posts featuring Ajay Major.

Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.

Ajay Major ASH24 Avyakta Kallam cancer CIBMTR Diffuse Large B-Cell Lymphoma DLBCL Jennifer Crombie Liso-cel Marcelo Pasquini Matthew Frigault OncoDaily Oncology Sairah Ahmed
Special Coverage
Blog
Nov 14, 2024, 12:35
Emphasizing the role of technology in clinical trials - Friends of Cancer Research
Insight
Nov 14, 2024, 12:33
Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie
Blog
Nov 14, 2024, 12:14
Targeted therapy advancements in NSCLC - ACS Journal Cancer
Blog
Nov 14, 2024, 12:09
Spotlighting Professor Raymond Chan - Flinders Caring Futures Institute
Blog
Nov 14, 2024, 11:56
Marbles Health Webinar: Distress Management for Cancer Patients
Insight
Nov 14, 2024, 11:49
2025 Cancer Discovery Early Career Award: Nominations Now Open
Blog
Nov 14, 2024, 11:46
Representing at AMIA 2024 - CRANE Lab
Blog
Nov 14, 2024, 11:45
Kristina Jankovic: Honored to record a podcast about Male Breast Cancer with ESO Oncology
Blog
Nov 14, 2024, 11:44
Estela Rodriguez: Accepting applications for Sylvester Comprehensive Cancer Center Cancer C-TIDE 2 year Postdoctoral Program
Blog
Nov 14, 2024, 11:41
Rayan Saleh Moussa: Barriers and enablers to clinical trial participation among Arabic-speaking cancer patients
Blog
Nov 14, 2024, 11:38
Amol Akhade: Seeking insights on DYPD mutation testing in cancer treatment
Blog
Nov 14, 2024, 11:30
OncoInfluencers to Follow on Social Media: Dr. Lacy Hubbard